You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenocarcinoma of Lung

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Local and Peripheral Immune Responsive Landscape Induced by

Not yet recruiting
  • Lung Adenocarcinoma
  • Local Cryoablation
    • (no location specified)
    Oct 24, 2023

    Tumor Microenvironment

    Active, not recruiting
    • Lung Adenocarcinoma
      • (no location specified)
      Aug 5, 2023

      Lung Adenocarcinoma Trial in Shijiazhuang (Tislelizumab,Platinum)

      Recruiting
      • Lung Adenocarcinoma
      • Shijiazhuang, Hebei, China
        The Fourth Hospital of Hebei Medical University (Hebei Tumor Hos
      Sep 24, 2023

      IA Lung Adenocarcinoma, Combined Segmentectomy Trial in Fuzhou (Patients receive subsegmentectomy)

      Active, not recruiting
      • IA Lung Adenocarcinoma
      • Combined Segmentectomy
      • Patients receive subsegmentectomy
      • Fuzhou, China
        Fujian Medical University Union Hospital
      Aug 2, 2023

      Invasiveness for Small-sized Lung Adenocarcinoma

      Recruiting
      • Lung Adenocarcinoma, Stage I
      • Invasiveness diagnosis
      • Wuhan, Hubei, China
        Union Hospital, Tongji Medical College, Huazhong University of S
      Apr 13, 2023

      Segmentectomy Versus Lobectomy for Lung Adenocarcinoma = 2cm

      Recruiting
      • Lung Adenocarcinoma
      • Lobectomy with systemic lymph node dissection
      • Segmentectomy with systemic lymph node dissection
      • Yangpu, Shanghai, China
        Shanghai Pulmonary Hospital
      Apr 20, 2023

      Novel Grading System of Resected Lung Adenocarcinoma

      Recruiting
      • Lung Adenocarcinoma
      • +2 more
      • Whole Slide Image based Deep Learning Signature
      • Zunyi, Guizhou, China
      • +2 more
      Jun 27, 2023

      Intraoperative Frozen Section Pathology to Guide Surgical

      Recruiting
      • Lung Adenocarcinoma
      • +2 more
      • Surgical resection
      • Shanghai, Shanghai, China
        Fudan University Cancer Center
      Mar 20, 2023

      Intraoperative Frozen Section Pathology to Guide Surgical

      Recruiting
      • Lung Adenocarcinoma
      • +2 more
      • Surgical resection
      • Shanghai, Shanghai, China
        Fudan University Cancer Center
      Mar 31, 2023

      Lung Adenocarcinoma, Frozen Section, Sublobar Resection Trial in Shanghai (Sublobar Resection)

      Recruiting
      • Lung Adenocarcinoma
      • +2 more
      • Sublobar Resection
      • Shanghai, Shanghai, China
        Fudan University Cancer Center
      Sep 4, 2023

      Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)

      Not yet recruiting
      • Non-small Cell Lung Adenocarcinoma
      • Squamous Cell Carcinoma of Lung
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jul 5, 2023

      Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

      Not yet recruiting
      • Lung Adenocarcinoma
      • +3 more
      • Serplulimab and Bevacizumab injection
      • (no location specified)
      Dec 21, 2022

      ALK-positive NSCLC Trial in Dallas (Ceritinib, Stereotactic ablative body radiation)

      Terminated
      Has Results
      • ALK-positive Non-small Cell Lung Cancer
      • Dallas, Texas
        UT Southwestern Medical Center
      Jan 31, 2023

      NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)

      Not yet recruiting
      • Non-Small Cell Lung Cancer Metastatic
      • (no location specified)
      Jan 18, 2023

      Novel Grading System of Clinical Stage I Lung Adenocarcinoma

      Recruiting
      • Lung Adenocarcinoma
      • +2 more
      • PET/CT-based Radiomics Signature
      • Zunyi, Guizhou, China
      • +3 more
      Feb 12, 2023

      Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Refractory Non-Small Cell Lung Cancer
      • Washington, District of Columbia
        Georgetown Lombardi Comprehensive Cancer Center
      Sep 1, 2023

      Intraoperative Frozen Section Pathology to Guide Surgical

      Recruiting
      • Lung Adenocarcinoma
      • +2 more
      • Surgical resection
      • Shanghai, Shanghai, China
        Fudan University Cancer Center
      Mar 20, 2023

      Lung Cancer Mutation Consortium Protocol

      Active, not recruiting
      • Adenocarcinoma of Lung, Stage IV
        • Aurora, Colorado
          University of Colorado Denver Cancer Center
        Jan 30, 2023

        Lung Adenocarcinoma Stage III, Lung Adenocarcinoma Stage IV, EGFR Gene Mutation Trial in Shanghai (Furmonertinib, Bevacizumab)

        Recruiting
        • Lung Adenocarcinoma Stage III
        • +2 more
        • Shanghai, Shanghai, China
          Shanghai Pulmonary Hospital
        Aug 13, 2022

        Adenocarcinoma of Lung Trial in United States (NovoTTF-200T System)

        Not yet recruiting
        • Adenocarcinoma of Lung
        • NovoTTF-200T System
        • Basking Ridge, New Jersey
        • +6 more
        Mar 3, 2023

        NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • Phase I - Mirdametinib - Level 1
        • +4 more
        • (no location specified)
        Jul 7, 2023

        Real-world Data of Afatinib Treatment in First-line Setting and

        Active, not recruiting
        • Non-squamous, Non-Small Cell Lung Cancer
        • Tokyo, Japan
          Nippon Boehringer Ingelheim Co., Ltd.
        Jan 9, 2023

        IASLC Grading System as a Predictor for EGFR-TKI Therapy

        Completed
        • Lung Cancer
        • IASLC grading system
        • Shanghai, Please Select, China
          Chaoqiang Deng
        Nov 9, 2023

        Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

        Not yet recruiting
        • Non-Small-Cell Lung Carcinoma
        • +2 more
        • Liquid biopsy
        • (no location specified)
        Jan 24, 2023

        Radiomics Combined With Frozen Section Prediction Model for

        Not yet recruiting
        • Lung Adenocarcinoma
        • radiomics
        • (no location specified)
        Jun 22, 2022